• Austria
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • UK
  • Bencard Adjuvant Systems
  • Allergy Therapeutics Plc
Allergy Therapeutics PLC
  • About us
    • About us
    • Overview
    • Mission and vision
    • Our markets
    • How we create value
    • The Opportunity
    • Our Stakeholders
    • Our Purpose & Values
    • Our Code
    about_us-gif.gif

    Global pioneers of convenient treatment for allergy and immune related disorders.

    Watch Video
  • Our science
    • Our science
    • Transforming lives
    • Delivering convenience
    • Specialist expertise
    • Research and development
      • Research and development
      • Product development
      • Investigator and Consultant Registry
      • Publications and posters
    Our science-gif.gif

    Transforming lives by delivering convience.

    Transforming lives
  • Our products
    • Our products
    • Information for Healthcare professionals
    • Information for patients
    GettyImages-587493720@2x.jpg

    As a Healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care.

    Information for healthcare professionals
  • Investors
    • Investors
    • Overview
    • At a glance
    • Financial highlights
    • Investment case
      • Investment case
      • Business model
      • Strategy
    • Regulatory news
    • Email alert
    • Results, reports and presentations
    • Financial Calendar
    • Share tools
      • Share tools
      • Share price summary
      • Detailed share chart
      • Historical Lookup
      • Share Price Calculator
    • Shareholder services
      • Shareholder services
      • Subscription of Shares and Debt Financing
      • AGM information
      • Registrar Details
      • Major shareholders
      • Analyst coverage
      • Electronic communications
    • AIM rule 26
    • Corporate governance
      • Corporate governance
      • Board of directors
      • Our board and its committees
    • Investor And Advisor Contacts
    GettyImages-587493720@2x.jpg

    We are a visionary immunology business with specialist experience in the research and development of allergy treatments.

    At a glance
  • Sustainability
    • Sustainability
    • Overview
    • Our People
    • Our patients
    • Our communities
    • Our planet
  • Careers
    • Careers
    • Discover more
    • Culture & values
    • Our locations
    • Career areas
    • Career vacancies
    careers-nav-item-image.jpg

    Work with us.

    Career vacancies
  • Get in touch
  • Our global sites
    • Austria
    • Germany
    • Italy
    • Netherlands
    • Spain
    • Switzerland
    • UK
    • Bencard Adjuvant Systems
    • Allergy Therapeutics Plc

Results, reports and presentations

  • Allergy Therapeutics PLC
  • Results, reports and presentations
  • Overview
  • At a glance
  • Financial highlights
  • Investment case
    • Business model
    • Strategy
  • Regulatory news
  • Email alert
  • Results, reports and presentations
  • Financial Calendar
  • Share tools
    • Share price summary
    • Detailed share chart
    • Historical Lookup
    • Share Price Calculator
  • Shareholder services
    • Subscription of Shares and Debt Financing
    • AGM information
    • Registrar Details
    • Major shareholders
    • Analyst coverage
    • Electronic communications
  • AIM Rule 26
  • Corporate governance
    • Board of directors
    • Our board and its committees
  • Investor and Advisor Contacts
Filter by:
  • All
  • Business
  • Financial
  • Product
September 2022

Preliminary results for the year ending 30 June 2022

Related materials PDF Presentation
September 2022

Fireside Chat with H.C. Wainwright

Related materials Presentation
May 2022

H.C. Wainwright Global Investment Conference - May 23-26, 2022

Related materials Presentation
March 2022

Interim Results for the six months ended 31 December 2021

Related materials PDF Presentation

Related Links

new-green-callout2021.jpg
Financial highlights
new-yellow-callout2021-2.jpg
Corporate governance
link-img-2.jpg
Investment case
footer-logo.svg
Linkedin icon
Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies
Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement
Contact us
Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700
© Allergy Therapeutics 2023. By Emperor